Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine Combined With Remimazolam in Knee Arthroscopy
NCT07838948Phase 4Completed
- Sponsor
- Wuhan Fourth Hospital
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in knee injury, sponsored by Wuhan Fourth Hospital. Started Apr 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
knee injury
Beyond the preview
Go deeper on NCT07838948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07838948.